Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Kirkland (QC): Merck Canada Inc
The findings imply that there could be possible therapeutic benefits from CBM588, although confirmation is needed from larger, placebo-controlled trials (Miyaoka et al., 2018)
Key Features Dual-mechanism design: GHRH-receptor agonism (CJC-1295) + GHSR agonism (Ipamorelin) for complementary GH-axis interrogation 99% Purity (HPLC/MS verified): Consistent material for reproducible protocols Protocol-friendly kinetics: Short, high-amplitude GH pulse (Ipamorelin) alongside prolonged GH/IGF-1 support (CJC-1295) in model systems GMP-compliant manufacturing (USA): Batch-to-batch reliability COA included: Full lot documentation Specifications Identity: CJC-1295 NO DAC /Ipamorelin USA cGMP Produced Form & Sizes: 10 mg or 20 mg blended vials Appearance: White to off-white lyophilized powder Purity: 99% (HPLC/MS verified) Manufacturing: GMP-compliant facility, USA Storage: 20 C, desiccated
Then ensure magnesium intake is adequate
Many patients also see improvements in blood sugar and cardiometabolic health
Women of childbearing potential should discuss contraceptive options and pregnancy planning with their prescribing clinician
